Initiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger! [0.03%]
心力衰竭患者的指南指导医学治疗的启动和升级：越来越好，越来越快，越来越强！
Edgar Francisco Carrizales-Sepúlveda,Alejandro Ordaz-Farías,José Arturo Vargas-Mendoza et al.
Edgar Francisco Carrizales-Sepúlveda et al.
Treatment for heart failure has experienced a major revolution in recent years, and current evidence shows that a combination of four medications (angiotensin receptor-neprilysin inhibitors + β-blockers + mineralocorticoid receptor antagon...
Shahrukh Hashmani,Yosef Manla,Nadya Al Matrooshi et al.
Shahrukh Hashmani et al.
Acute myocarditis is an inflammatory disease of the heart that may occur in the setting of infection, immune system activation or exposure to certain drugs. Often, it is caused by viruses, whereby the clinical course is usually benign; howe...
Loreena Hill,Anne McNulty,James McMahon et al.
Loreena Hill et al.
Cardiology services within primary care often focus on disease prevention, early identification of illness and prompt referral for diagnosis and specialist treatment. Due to advances in pharmaceuticals, implantable cardiac devices and surgi...
Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction [0.03%]
射血分数保留的心力衰竭的流行病学、临床特征和病因特异性结局
Chris J Kapelios,Bahira Shahim,Lars H Lund et al.
Chris J Kapelios et al.
Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with preserved ejection fraction (HFpEF) has traditionally received less attention than its main counterpart, HF with reduced ejection fraction (HFrEF). The i...
Rafael de la Espriella,Gonzalo Núñez-Marín,Pau Codina et al.
Rafael de la Espriella et al.
Acute heart failure (AHF) is a complex clinical syndrome that requires prompt diagnosis, risk stratification and effective treatment strategies to reduce morbidity and mortality. Biomarkers are playing an increasingly important role in this...
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management [0.03%]
法布吕病的心血管受累：诊断策略、预后评估和治疗的新进展
Emanuele Monda,Luigi Falco,Giuseppe Palmiero et al.
Emanuele Monda et al.
Cardiovascular involvement is common in Fabry's disease and is the leading cause of morbidity and mortality. The research is focused on identifying diagnostic clues suggestive of cardiovascular involvement in the preclinical stage of the di...
Bahira Shahim,Chris J Kapelios,Gianluigi Savarese et al.
Bahira Shahim et al.
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Although the incidence of HF has stabilised worldwide and seems to be declining in developed countries, the prevalence i...
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction [0.03%]
射血分数保留的心力衰竭神经激素调节的病理生理原理及临床证据
Vincenzo Castiglione,Francesco Gentile,Nicolò Ghionzoli et al.
Vincenzo Castiglione et al.
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome resulting from the interaction between cardiac diseases, comorbidities and ageing. HFpEF is characterised by the activation of neurohormonal axes, namely of ...
Effects of Sacubitril/Valsartan on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and the Role of Percentage of Delayed Enhancement Measured by Cardiac Magnetic Resonance in Predicting Therapeutic Response: A Multicentre Study [0.03%]
ARNI对射血分数降低型心力衰竭患者运动能力的影响及心脏磁共振测量的延迟强化百分比预测疗效价值的多中心研究
Cinzia Nugara,Francesco Giallauria,Giuseppe Vitale et al.
Cinzia Nugara et al.
Background: This study aims to evaluate the cardiopulmonary effects of sacubitril/valsartan therapy in patients with heart failure with reduced ejection fraction (HFrEF), investigating a possible correlation with the degree of myocardial fi...
Fraser J Graham,Antonio Iaconelli,Piotr Sonecki et al.
Fraser J Graham et al.
Water and salt retention, in other words congestion, are fundamental to the pathophysiology of heart failure and are important therapeutic targets. Echocardiography is the key tool with which to assess cardiac structure and function in the ...